Login / Signup

Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator.

Lucía Romero-PinelLaura BauElisabet MatasIsabel LeónRoser JuvanyRamon JódarAntonio Martínez-YélamosSergio Martínez-Yélamos
Published in: PloS one (2022)
The treatment cost per year to achieve a relapse-free patient was stable during successive measurements in the same population. Therefore, it may be considered a good real-world health indicator for patients with RRMS treated with DMTs.
Keyphrases
  • multiple sclerosis
  • public health
  • healthcare
  • case report
  • mental health
  • health information
  • free survival
  • health promotion
  • white matter
  • risk assessment
  • climate change
  • smoking cessation